Citation only
via OpenAlex
GSK-3 is essential in the pathogenesis of Alzheimer's disease
Journal of Alzheimer s Disease · 2006 · ▲ 396 citations
Abstract
Glycogen synthase kinase-3 (GSK-3) is a pivotal molecule in the development of Alzheimer's disease (AD). GSK-3beta is involved in the formation of paired helical filament (PHF)-tau, which is an integral component of the neurofibrillary tangle (NFT) deposits that disrupt neuronal function, and a marker of neurodegeneration in AD. GSK-3beta has exactly the same oligonucleotide sequence as tau-protein kinase I (TPKI), which was first purified from the microtubule fraction of bovine brain. Initially, we discovered that GSK-3beta was involved in amyloid-beta (Abeta)-induced neuronal death in rat hippocampal cultures. In the present review, we discuss our initial in vitro results and additional investigations showing that Abeta activates GSK-3beta through impairment of phosphatidylinositol-3 (PI3)/Akt signaling; that Abeta-activated GSK-3beta induces hyperphosphorylation of tau, NFT formation, neuronal death, and synaptic loss (all found in the AD brain); that GSK-3beta can induce memory deficits in vivo; and that inhibition of GSK-3alpha (an isoform of GSK-3beta) reduces Abeta production. These combined results strongly suggest that GSK-3 activation is a critical step in brain aging and the cascade of detrimental events in AD, preceding both the NFT and neuronal death pathways. Therefore, therapeutics targeted to inhibiting GSK-3 may be beneficial in the treatment of this devastating disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3233/jad-2006-9s335
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
Takashima, A. (2006). GSK-3 is essential in the pathogenesis of Alzheimer's disease. <em>Journal of Alzheimer s Disease</em>. https://doi.org/10.3233/jad-2006-9s335
Vancouver
Takashima A. GSK-3 is essential in the pathogenesis of Alzheimer's disease. Journal of Alzheimer s Disease. 2006. doi:10.3233/jad-2006-9s335.
BibTeX
@article{akihiko2006GSKise,
title = {GSK-3 is essential in the pathogenesis of Alzheimer's disease},
author = {Akihiko Takashima},
journal = {Journal of Alzheimer s Disease},
year = {2006},
doi = {10.3233/jad-2006-9s335},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Histochemistry & Cytochemistry 1996
Open access · OA
Localization of transglutaminase in hippocampal neurons: implications for Alzheimer's disease.
Journal of Neurochemistry 2006
Open access · OA
REVIEW: Pin1 in Alzheimer's disease
Acta Neuropathologica 2017
Preprint · OA
IRE1 signaling exacerbates Alzheimer’s disease pathogenesis
Journal of Alzheimer s Disease 2010
Open access · CC-BY
Neuronal Calcium Signaling, Mitochondrial Dysfunction, and Alzheimer's Disease
Journal of Neurology Neurosurgery & Psychiatry 2003
Open access · OA
Intrathecal inflammation precedes development of Alzheimer's disease
University of California, Los Angeles 2022
Open access · US-GOV